Vancomycin-resistant Staphylococcus aureus: Difference between revisions
Hardik Patel (talk | contribs) No edit summary |
Hardik Patel (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} VRSA | {{SK}} VRSA; VISA / VRSA: vancomycin-intermediate/resistant Staphylococcus aureus | ||
==[[Vancomycin-resistant Staphylococcus aureus overview|Overview]]== | ==[[Vancomycin-resistant Staphylococcus aureus overview|Overview]]== | ||
Revision as of 16:26, 17 December 2012
For patient information click here
|
Vancomycin-resistant Staphylococcus aureus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vancomycin-resistant Staphylococcus aureus On the Web |
|
American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus |
|
Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus |
|
Risk calculators and risk factors for Vancomycin-resistant Staphylococcus aureus |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: VRSA; VISA / VRSA: vancomycin-intermediate/resistant Staphylococcus aureus
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Vancomycin-Resistant Staphylococcus Aureus from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | EKG | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies